The Current Status and Future Perspectives of Beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients

Beta-lactams (BL) are the first line agents for the antibiotic management of critically ill patients with sepsis or septic shock. BL are hydrophilic antibiotics particularly subject to unpredictable concentrations in the context of critical illness because of pharmacokinetic (PK) and pharmacodynamic...

Descripción completa

Detalles Bibliográficos
Autores principales: Novy, Emmanuel, Martinière, Hugo, Roger, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135361/
https://www.ncbi.nlm.nih.gov/pubmed/37107043
http://dx.doi.org/10.3390/antibiotics12040681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135361/
https://www.ncbi.nlm.nih.gov/pubmed/37107043
http://dx.doi.org/10.3390/antibiotics12040681

Ejemplares similares